PHARMA INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
PHARMA INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated – company is not active.
Incorporation date
28/01/2005Share capital
No dataPrimary activity
No dataRepresentatives
0Representatives rights
DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST UPOWAŻNIONY KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-113,192Net Profit (zł)
-113,192Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 12,652 |
| -121,079 |
| -121,079 |
| -16.59 |
| 0.24 |
| -956.99 |
| -625,452 |
| 275,677 |
| 643,000 |
| 209,484 |
| 2023 |
|---|
| 196,973 |
| -208,156 |
| -208,156 |
| -0.89 |
| 0.18 |
| -105.68 |
| -833,608 |
| 213,699 |
| 767,000 |
| 108,358 |
| 2024 |
|---|
| 0 |
| -113,192 |
| -113,192 |
| - |
| 0.10 |
| - |
| -946,800 |
| 211,786 |
| 767,000 |
| 10,030 |
| 2024 |
|---|
| 0 |
| -113,192 |
| -113,192 |
| - |
| 0.10 |
| - |
| -946,800 |
| 211,786 |
| 767,000 |
| 10,030 |
Turnover (zł)
2024
Turnover (zł)
0 zł
-100 % *
Profit before tax (zł)
-113,192 zł
46 % *
Net Profit (zł)
-113,192 zł46 % *
Working capital requirement (%)
-Liquidity ratio
0.10 -44.44 % *
Net profitability (%)
-Equity (zł)
-946,800 zł-14 % *
Current liabilities (zł)
211,786 zł-1 % *
Non current liabilities (zł)
767,000 zł
0 % *
Non-current Assets (zł)
10,030 zł
-91 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
PHARMA INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI Documents
Date | Description |
|---|---|
08/04/2025 | OD 01.01.2024 DO 31.12.2024 |
11/09/2024 | OD 01.01.2023 DO 31.12.2023 |
05/07/2023 | OD 01.01.2022 DO 23.11.2022 |
05/07/2023 | OD 24.11.2022 DO 31.12.2022 |
15/09/2022 | OD 01.01.2021 DO 31.12.2021 |